Gossamer Bio, Inc.

NASDAQ:GOSS

1.45 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019201820172016
Operating Activities:
Net Income -56.528-179.817-229.378-234.004-243.36-180.307-146.969-6.771-0.083
Depreciation & Amortization 4.1514.3854.4295.1674.2683.0890.29700
Deferred Income Tax 0000.359-0.158-2.392000
Stock Based Compensation 20.61928.51842.55332.00838.74820.81930.9470.0320
Change In Working Capital 0-14.841-4.4590.774-3.09510.1215.0220.9940.103
Accounts Receivables 000000000
Inventory 000000000
Accounts Payables -1.6563.99-1.813-4.4286.984-1.3992.0850.0570.103
Other Working Capital 0-18.831-2.6465.202-10.07911.51912.9370.9370.103
Other Non Cash Items 28.292.597-0.1776.80627.2373.83749.6590.0320.103
Operating Cash Flow -3.468-159.158-187.032-188.89-176.36-144.834-51.044-5.7450.02
Investing Activities:
Investments In Property Plant And Equipment 00-0.475-1.621-24.883-6.566-21.21100
Acquisitions Net 00-0.0650.07523.383.6-17.72100
Purchases Of Investments -494.777-441.67-238.06-152.031-108.968-499.079-123.500
Sales Maturities Of Investments 523.8330.7237.536.225349.193358.501000
Other Investing Activites 000.065-0.075-23.38-3.617.72100
Investing Cash Flow 29.023-110.97-1.035-117.427215.342-147.144-144.71100
Financing Activities:
Debt Repayment 0-11.613-5.8060193.59628.222-0.0460.04
Common Stock Issued 0.464201.323119.9463.329117.11291.311229.55200
Common Stock Repurchased 0.62900000000
Dividends Paid 000000000
Other Financing Activities -11.4880.8882.953.3291.834293.356300.89900
Financing Cash Flow -11.488190.154117.093.329312.54321.578300.85960.04
Other Information:
Effect Of Forex Changes On Cash -0.1020.11-0.517-0.1650.0090.07000
Net Change In Cash 13.965-79.864-71.494-303.153351.53129.67105.1040.2550
Cash At End Of Period 46.07432.109111.973183.467486.62135.089105.4190.3150.06